News
PLAST_CELL presented at Festival of Biologics
On 15-17th October 2024, Cherry Biotech participated in the Festival of Biologics in Basel, Switzerland, Europe’s largest biologics event. Cherry Biotech presented the PLAST_CELL project and their latest innovative CubiX prototype, designed to confine cells and precisely control environmental conditions. This novel tool, combined with the data currently generated by the PLAST_CELL consortium, will enable to quantify phenotypic changes in cancer cells, shedding light on cancer cell plasticity and aggressiveness.
Second Annual Meeting together with our Ethics Advisors
On 17-18th October 2023, we held the Second Annual Meeting of PLAST_CELL at the PRBB in Barcelona. It was a hands-on meeting, where participants went to visit the labs of Verena Ruprecht and Toni Celià-Terrassa and even with a demonstration of the microfluidics device from Cherry Biotech! We also welcomed our newly established Ethics Advisory […]
Cancer cell ‘decathlon’ to help predict tumour aggressiveness and metastasis
We celebrate the one-year anniversary of an ongoing research project funded by the European Innovation Council which aims to quantify a cancer cell’s ability to respond to environmental stress that threatens its survival, a key indicator of tumour progression and aggressiveness. In response to changing environments that threaten their survival, cancer cells have an extraordinary […]
First in-person meeting of the PLAST_CELL consortium
After six months of mostly online interactions, the whole PLAST_CELL consortium met on November 3, 2022, for the first time in person in Barcelona. The objective of this gathering was to foster active cooperation among the partners, share ongoing work and outline the plan for the upcoming months as well as the actions that need to […]
Virtual kick-off meeting of the PLAST_CELL project
On 5 th May 2022, we held a virtual Kick-off Meeting of our project that is funded by a European Innovation Council (EIC) Pathfinder Grant. The interdisciplinary consortium is formed by 5 partners: CRG, ICFO, IMIM, EMBL-EBI and Cherry Biotech. Together, we will pioneer the development of a microfluidics- based imaging platform to study cancer […]